Prosecution Insights
Last updated: April 19, 2026
Application No. 18/311,606

SINGLE SENSOR FOR PHYSIOLOGIC SIGNAL MEASUREMENT WITH POSITION AND TISSUE PROXIMITY INDICATION

Non-Final OA §102
Filed
May 03, 2023
Examiner
MALAMUD, DEBORAH LESLIE
Art Unit
3792
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
BIOSENSE WEBSTER (ISRAEL) LTD.
OA Round
1 (Non-Final)
79%
Grant Probability
Favorable
1-2
OA Rounds
3y 5m
To Grant
89%
With Interview

Examiner Intelligence

Grants 79% — above average
79%
Career Allow Rate
666 granted / 847 resolved
+8.6% vs TC avg
Moderate +10% lift
Without
With
+10.0%
Interview Lift
resolved cases with interview
Typical timeline
3y 5m
Avg Prosecution
44 currently pending
Career history
891
Total Applications
across all art units

Statute-Specific Performance

§101
10.7%
-29.3% vs TC avg
§103
27.0%
-13.0% vs TC avg
§102
43.5%
+3.5% vs TC avg
§112
15.4%
-24.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 847 resolved cases

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Claims 11-20 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected species, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on 03 February 2026. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1, 4-6 and 9-10 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Vij et al (U.S. 2014/0024909). Vij discloses (par. 0070) a coaxial wire (“coaxial cable”) wound around a longitudinal axis to form a sensor for a medical probe (par. 0061, especially “The illustrated catheter distal end portion 106 includes a pair of EGM (electrogram) sensing electrodes 82 positioned between the first and second tracking coils 112, 114, and a sensing electrode 82 positioned between the tracking coil 114 and the tracking coil 122.”), the coaxial wire comprising: a core conductive member surrounded by a portion of the coaxial wire (par. 0070, “conductive center conductor”) ;an inner insulation (par. 0070, “dielectric layer”) over the core conductive member and electrically insulating the core conductive member from an external environment to the sensor (par. 0070, “The center conductor of a respective coaxial cable C.sub.2 is isolated from outside effects”); an outer conductive member (par. 0070, “conductive shield”; also 500 in par. 0073-0081) extending over the inner insulation and electrically insulated from the core conductive member by the inner insulation; and an outer insulation (par. 0070, “insulating jacket”; also disclosed as 600 in par. 0073-0081) over a portion of the outer conductive member such that uninsulated portions of the outer conductive member are exposed to the external environment to the sensor at two or more windings of the coaxial wire forming the sensor (par. 0073, “At one end 500b of the RF shield 500, the inner and outer conductors 502, 504 are shorted (i.e., electrically connected). At the other end 500a, the inner and outer conductors 502, 504 are not connected (i.e., the inner and outer conductors 502, 504 are open circuited).”). Regarding claim 4, Vij discloses (par. 0069) the uninsulated portions being configured to contact tissue and output electrocardiogram (ECG) signals through the tissue (“EGM signals are detected by the sensing electrodes 82 that are in close proximity to cardiac tissue.”). Regarding claim 5, Vij discloses (par. 0066) the outer conductive member being configured to vary in impedance in response to changes in conductivity of the external environment to which the uninsulated portions are exposed (the CSM senses the MRI field, and controls the magnitude of the impedance to perform heat management in the presence of the MRI field). Regarding claim 6, Vij discloses (par. 0049) the outer conductive member being configured to provide output signals indicative of changes in conductivity of the external environment to which the uninsulated portions are exposed (displaying the changes in position that are related to detected changes in the electric fields). Regarding claim 9, Vij discloses (Figures 11A-C) the core conductive member, inner insulation, and outer conductive member being coaxial to each other and wound about the longitudinal axis. Regarding claim 10, Vij discloses (Figure 12) adjacent windings with uninsulated portions of the outer conductive member such that the uninsulated portions are separated by a gap when the sensor is aligned with a straight longitudinal axis, and bending the sensor causes the gap to collapse to electrically short the uninsulated portions of the adjacent windings to thereby provide an indication of degree of curvature of the sensor (par. 0081, where spaced apart RF shields are provided to “allow articulation of the sheath 600 and without any stiff points”.). Claims 1-3 and 7-9 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Andreason et al (U.S. 2019/0025040). Andreason discloses (par. 0231) a coaxial wire wound around a longitudinal axis to form a sensor for a medical probe, the coaxial wire comprising: a core conductive member surrounded by a portion of the coaxial wire; an inner insulation over the core conductive member and electrically insulating the core conductive member from an external environment to the sensor; an outer conductive member (par. 0238-0241) extending over the inner insulation and electrically insulated from the core conductive member by the inner insulation; and an outer insulation over a portion of the outer conductive member such that uninsulated portions of the outer conductive member are exposed to the external environment to the sensor at two or more windings of the coaxial wire forming the sensor (“the first inductor coil includes a wire coated in a first insulator and wound about the first core. In some of these cases, the wire includes a first terminal and a second terminal. In some of these cases, the control circuit is configured to apply the excitation signal between the first and second terminals.”). Regarding claim 2, Andreason discloses (par. 0165) the core conductive member being configured to measure one or more referential magnetic fields to provide signals indicative of a position of the sensor within a body. Regarding claim 3, Andreason discloses (par. 0123) the core conductive member being configured output signals based on a change in magnetic flux through the sensor. Regarding claim 7, Andreason discloses (par. 0165) the outer conductive member being configured to measure one or more referential magnetic fields to provide signals indicative of a position of the sensor within a body. Regarding claim 8, Andreason discloses (par. 0123) the outer conductive member being configured output signals based on a change in magnetic flux through the sensor. Regarding claim 9, Andreason discloses (Figures 12A-12G) the core conductive member, inner insulation, and outer conductive member being coaxial to each other and wound about the longitudinal axis. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to DEBORAH L MALAMUD whose telephone number is (571)272-2106. The examiner can normally be reached Mon - Fri 1:00-9:30 Eastern. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Unsu Jung can be reached at (571) 272-8506. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /DEBORAH L MALAMUD/Primary Examiner, Art Unit 3792
Read full office action

Prosecution Timeline

May 03, 2023
Application Filed
Mar 03, 2026
Non-Final Rejection — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12598433
VAGAL NERVE STIMULATION DEVICES AND METHODS
2y 5m to grant Granted Apr 07, 2026
Patent 12594418
DEVICES AND METHODS FOR NERVE STIMULATION
2y 5m to grant Granted Apr 07, 2026
Patent 12588868
BIPOLAR MAPPING SUCTION DEVICE
2y 5m to grant Granted Mar 31, 2026
Patent 12586687
SYSTEMS AND METHODS OF DEDUPLICATING DATA COLLECTED BY AN IMPLANTABLE MEDICAL DEVICE
2y 5m to grant Granted Mar 24, 2026
Patent 12575795
NON-INVASIVE PREDICTION OF RISK FOR SUDDEN CARDIAC DEATH
2y 5m to grant Granted Mar 17, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
79%
Grant Probability
89%
With Interview (+10.0%)
3y 5m
Median Time to Grant
Low
PTA Risk
Based on 847 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month